GW&K Investment Management LLC Has $16.18 Million Stock Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

GW&K Investment Management LLC reduced its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 9.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 162,224 shares of the medical instruments supplier’s stock after selling 16,415 shares during the quarter. GW&K Investment Management LLC owned about 0.67% of ICU Medical worth $16,181,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. M&T Bank Corp raised its position in shares of ICU Medical by 5.4% during the third quarter. M&T Bank Corp now owns 4,661 shares of the medical instruments supplier’s stock worth $555,000 after purchasing an additional 239 shares during the period. Empower Advisory Group LLC increased its position in shares of ICU Medical by 8.3% during the third quarter. Empower Advisory Group LLC now owns 72,145 shares of the medical instruments supplier’s stock worth $8,586,000 after acquiring an additional 5,534 shares in the last quarter. Nuance Investments LLC raised its holdings in shares of ICU Medical by 45.2% in the 3rd quarter. Nuance Investments LLC now owns 292,670 shares of the medical instruments supplier’s stock worth $34,831,000 after acquiring an additional 91,137 shares during the last quarter. Swiss National Bank lifted its position in ICU Medical by 1.1% in the 3rd quarter. Swiss National Bank now owns 45,019 shares of the medical instruments supplier’s stock valued at $5,358,000 after acquiring an additional 500 shares in the last quarter. Finally, Gamco Investors INC. ET AL boosted its stake in ICU Medical by 1.1% during the 3rd quarter. Gamco Investors INC. ET AL now owns 24,950 shares of the medical instruments supplier’s stock valued at $2,969,000 after purchasing an additional 278 shares during the last quarter. Institutional investors own 96.10% of the company’s stock.

ICU Medical Trading Up 3.4 %

NASDAQ:ICUI traded up $3.52 on Wednesday, hitting $106.26. The stock had a trading volume of 24,760 shares, compared to its average volume of 245,504. ICU Medical, Inc. has a 1 year low of $78.28 and a 1 year high of $196.57. The firm’s fifty day simple moving average is $100.67 and its two-hundred day simple moving average is $97.31. The company has a current ratio of 2.61, a quick ratio of 1.09 and a debt-to-equity ratio of 0.76.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Tuesday, February 27th. The medical instruments supplier reported $1.24 EPS for the quarter, topping analysts’ consensus estimates of $0.85 by $0.39. ICU Medical had a positive return on equity of 5.38% and a negative net margin of 2.63%. The business had revenue of $587.86 million for the quarter, compared to analyst estimates of $564.77 million. Research analysts forecast that ICU Medical, Inc. will post 3.53 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, KeyCorp increased their price objective on ICU Medical from $134.00 to $136.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 28th.

Insider Transactions at ICU Medical

In related news, Director Elisha W. Finney sold 300 shares of the stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $104.95, for a total transaction of $31,485.00. Following the completion of the transaction, the director now owns 2,129 shares in the company, valued at $223,438.55. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other news, insider Ben Sousa sold 2,000 shares of the stock in a transaction on Friday, May 10th. The stock was sold at an average price of $105.55, for a total transaction of $211,100.00. Following the completion of the transaction, the insider now owns 1,319 shares in the company, valued at approximately $139,220.45. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Elisha W. Finney sold 300 shares of ICU Medical stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $104.95, for a total value of $31,485.00. Following the completion of the sale, the director now directly owns 2,129 shares of the company’s stock, valued at approximately $223,438.55. The disclosure for this sale can be found here. Insiders have sold 26,562 shares of company stock worth $2,788,117 in the last ninety days. Company insiders own 6.70% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.